Advertisement
Screener

ClearPoint Neuro, Inc. (CLPT) Beta

ClearPoint Neuro, Inc. (CLPT) Beta

  • Beta · 5-year monthly: Value 1.27; Formula and calculation Saved five-year monthly beta; measures historical sensitivity to the benchmark..

Beta

Overview →

Financial period ending 2026-08-31; current quote 2026-08-31. Amounts retain their stated periods and units.

MetricValueFormula and calculation
Beta · 5-year monthly1.27Saved five-year monthly beta; measures historical sensitivity to the benchmark.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingBeta
2026-08-311.27

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
CARLSMED, INC. (CARL)United States$0.405B
Orthofix Medical Inc. (OFIX)$0.373B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Embecta Corp. (EMBC)United States$0.319B2.10